What departments does TransCode Therapeutics, Inc. have?

TransCode Therapeutics, Inc. has employees across 5 departments including Entrepreneurship, Finance, Research, Healthcare Services, Engineering.

What is the largest department at TransCode Therapeutics, Inc.?

The largest department at TransCode Therapeutics, Inc. is Entrepreneurship with 2 employees.

Where are TransCode Therapeutics, Inc. employees located globally?

TransCode Therapeutics, Inc. has employees across 2 continents and 3 countries including Netherlands, Belgium, United States Of America.

How has TransCode Therapeutics, Inc.'s team size changed over time?

TransCode Therapeutics, Inc.'s team has decreased from approximately 13 to 12 employees based on available data.

TransCode Therapeutics, Inc. Employee Directory

Q: Who are TransCode Therapeutics, Inc.'s key employees and leadership?

TransCode Therapeutics, Inc.'s key employees include: Co-Founder, Chief Executive Officer, Director: M. D., Chief Executive Officer: Q. L., Chief Financial Officer: E. B., Chief Scientific Officer: Z. M., Chief Scientist: P. L..

Biotechnology ResearchMassachusetts, United States11-50 Employees

TransCode Therapeutics, Inc. is a biotechnology research company based in Newton, Massachusetts, with 11 to 50 employees and a website at transcodetherapeutics.com. Its core approach uses a proprietary delivery platform called TTX to transport targeted therapeutics to cancer cells, with the lead candidate TTX-MC138 designed to target microRNA-10b, described as a master regulator of metastatic cell viability across multiple cancers. TransCode positions itself as a clinical-stage oncology company pursuing RNA and immuno-oncology therapeutics and maintains a rapidly expanding platform of drug candidates for various tumor indications. The company has licensed three oncolytic adenovirus candidates—UIO-524, UIO-525, and UIO-526—from Unleash Immuno Oncolytics, and has entered into a sponsored research agreement with Michigan State University. Public information indicates the company trades on Nasdaq under the ticker RNAZ and appointed Anna Moore as Chair of its Scientific Advisory Board in April 2026.

TransCode Therapeutics, Inc. Global Highlights

North America
25

United States Of America
25

Europe
2

Netherlands
1
Belgium
1

TransCode Therapeutics, Inc.'s Leadership

Q. L.
Chief Executive Officer
Mobile Phone
Email
E. B.
Chief Financial Officer
Mobile Phone
Email
Z. M.
Chief Scientific Officer
Mobile Phone
Email
P. L.
Chief Scientist
Mobile Phone
Email
S. D.
Vice President Of Clinical Operations
Mobile Phone
Email
M. D.
Co-Founder, Chief Executive Officer, Director
Mobile Phone
Email
A. M.
Co-Founder
Mobile Phone
Email
T. F.
Vice President
Mobile Phone
Email

TransCode Therapeutics, Inc. Employee Metrics

100%

50%

0%

2026

2025

Biotechnology
Entrepreneurship
Administrative
Business Development
Accounting
Other
Business
Consultant

Contact profiles from TransCode Therapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

A. M.
Co-Founder
Mobile Phone
Email
Oct 16, 2024
E. B.
Chief Financial Officer
Mobile Phone
Email
Oct 22, 2024
M. D.
Co-Founder, Chief Executive Officer, Director
Mobile Phone
Email
Jun 01, 2026
Q. L.
Chief Executive Officer
Mobile Phone
Email
Oct 18, 2024
Z. M.
Chief Scientific Officer
Mobile Phone
Email
Jul 25, 2026
P. L.
Chief Scientist
Mobile Phone
Email
Mar 31, 2025
S. D.
Vice President Of Clinical Operations
Mobile Phone
Email
Apr 27, 2026
T. F.
Vice President
Mobile Phone
Email
Sep 26, 2024
E. M.
Independent Director
Mobile Phone
Email
NetherlandsNorth Holland
Jul 23, 2026
M. J.
Senior Development Officer
Mobile Phone
Email
BelgiumBrussels
Jul 23, 2026

Frequently Asked Questions

What is TransCode Therapeutics, Inc. known for?

TransCode Therapeutics, Inc. was founded in 2016 operates in the Biotechnology Research industry. Explore TransCode Therapeutics, Inc.'s company overview page for more information.

What is TransCode Therapeutics, Inc.'s most common email format?

TransCode Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more TransCode Therapeutics, Inc. email formats with LeadIQ.

How many employees does TransCode Therapeutics, Inc. have currently?

TransCode Therapeutics, Inc. has approximately 16 employees as of July 2026. These team members are located across 2 continents, including North AmericaEurope.

Who are TransCode Therapeutics, Inc.'s key employees and leadership?

As of July 2026, TransCode Therapeutics, Inc.'s key employees include:

Chief Executive Officer: Q. L.
Chief Financial Officer: E. B.
Chief Scientific Officer: Z. M.
Chief Scientist: P. L.
Vice President Of Clinical Operations: S. D.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

TransCode Therapeutics, Inc. Employee Directory

Find TransCode Therapeutics, Inc. employees' phone numbers or email addresses

Name search is limited — try advanced search instead